pf 5901 has been researched along with 15-hydroxy-5,8,11,13-eicosatetraenoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, UR; Coutts, SM; Gordon, RJ; Khandwala, A; Musser, JH; Neiss, ES; Pruss, TP; Sciortino, S; Van Inwegen, R; Weinryb, I | 1 |
| Carter, GW; Dyer, RD; Holms, JH; Mazdiyasni, H; Ratajczyk, JD; Summers, JB | 1 |
| Derian, CK; Lewis, DF | 1 |
3 other study(ies) available for pf 5901 and 15-hydroxy-5,8,11,13-eicosatetraenoic acid
| Article | Year |
|---|---|
Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.
Topics: Animals; Arachidonate Lipoxygenases; Hydroxyeicosatetraenoic Acids; Indicators and Reagents; Lipoxygenase Inhibitors; Lung; Neutrophils; Phenyl Ethers; Rats; SRS-A; Structure-Activity Relationship | 1987 |
Hydroxamic acid inhibitors of 5-lipoxygenase.
Topics: Arachidonate Lipoxygenases; Cell Line; Hydroxamic Acids; Kinetics; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Molecular Conformation; Protein Binding; Structure-Activity Relationship | 1987 |
Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Animals; Aorta; Arachidonate 15-Lipoxygenase; Benzyl Compounds; Cells, Cultured; Copper; Copper Sulfate; Endothelium, Vascular; Enzyme Activation; Hydroxamic Acids; Hydroxyeicosatetraenoic Acids; Indomethacin; Linoleic Acid; Linoleic Acids; Lipoproteins, LDL; Lipoxygenase Inhibitors; Masoprocol; Oxidation-Reduction; Quinolines; Swine; Umbilical Veins | 1992 |